Successful Long-Term Enzyme Replacement Therapy in a Patient with Delayed-Onset ADA Deficiency
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Successful Long-Term Enzyme Replacement Therapy in a Patient with Delayed-Onset ADA Deficiency ; volume:45 ; number:1 ; day:12 ; month:9 ; year:2024 ; pages:1-4 ; date:12.2025
Journal of clinical immunology ; 45, Heft 1 (12.9.2024), 1-4, 12.2025
- Klassifikation
-
Medizin, Gesundheit
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10875-024-01794-7
- URN
-
urn:nbn:de:101:1-2411262110218.169564088055
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Toskov, Vasil
- Bali, Pawan
- Hershfield, Michael S.
- Ehl, Stephan
- Speckmann, Carsten
- SpringerLink (Online service)
Ähnliche Objekte (12)
Successful long-term enzyme replacement therapy in a patient with delayed-onset ADA deficiency
Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox
Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation
Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox
Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation
Prospective newborn screening for SCID in Germany: A first analysis by the pediatric immunology working group (API)
Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype
Disease pathophysiology in murine models of primary hemophagocytic lymphohistiocytosis: triggers and effectors
Efficacy of T cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis
Tracing the specificity of CRISPR-Cas nucleases in clinically relevant human cells
Cell versus cytokine – directed therapies for hemophagocytic lymphohistiocytosis (HLH) in inborn errors of immunity
Immunomodulatory effects of different Cannabis extracts on human primary lymphocytes
Successful long-term enzyme replacement therapy in a patient with delayed-onset ADA deficiency
Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox
Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation
Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox
Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation
Prospective newborn screening for SCID in Germany: A first analysis by the pediatric immunology working group (API)
Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype
Disease pathophysiology in murine models of primary hemophagocytic lymphohistiocytosis: triggers and effectors
Efficacy of T cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis
Tracing the specificity of CRISPR-Cas nucleases in clinically relevant human cells
Cell versus cytokine – directed therapies for hemophagocytic lymphohistiocytosis (HLH) in inborn errors of immunity
Immunomodulatory effects of different Cannabis extracts on human primary lymphocytes
Successful long-term enzyme replacement therapy in a patient with delayed-onset ADA deficiency
Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox
Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation
Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox
Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation
Prospective newborn screening for SCID in Germany: A first analysis by the pediatric immunology working group (API)
Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype
Disease pathophysiology in murine models of primary hemophagocytic lymphohistiocytosis: triggers and effectors
Efficacy of T cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis
Tracing the specificity of CRISPR-Cas nucleases in clinically relevant human cells
Cell versus cytokine – directed therapies for hemophagocytic lymphohistiocytosis (HLH) in inborn errors of immunity